| Inflammation and chemerin in colorectal cancer S Erdogan, FM Yilmaz, O Yazici, A Yozgat, S Sezer, N Ozdemir, S Uysal, ... Tumor Biology 37, 6337-6342, 2016 | 67 | 2016 |
| Assessment of prognostic value of F Kos, C Hocazade, M Kos, D Uncu, E Karakas, M Dogan, H Uncu, ... Asian Pacific journal of cancer prevention 16 (9), 2015 | 66 | 2015 |
| Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey A Ulas, K Silay, S Akinci, D Dede, M AKINCI, M ŞENDUR, E Cubukcu, ... Asian Pacific Journal of Cancer Prevention 16 (5), 2015 | 62 | 2015 |
| Targeted therapies in gastric cancer and future perspectives O Yazici, MAN Sendur, N Ozdemir, S Aksoy World journal of gastroenterology 22 (2), 471, 2016 | 48 | 2016 |
| A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma GU Erdem, MAN Sendur, NY Ozdemir, O Yazıcı, N Zengin Current medical research and opinion 31 (4), 743-756, 2015 | 48 | 2015 |
| Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy C Karacin, T Eren, E Zeynelgil, GI Imamoglu, M Altinbas, I Karadag, ... Future Oncology 17 (33), 4447-4456, 2021 | 38 | 2021 |
| ABO and Rh blood groups and risk of colorectal adenocarcinoma Y Ürün, N Ozdemir, G Utkan, H Akbulut, B Savaş, B Oksuzoglu, D Öztuna, ... Asian Pacific Journal of Cancer Prevention 13 (12), 2012 | 37 | 2012 |
| It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting NY Özdemir, H Abalı, B Öksüzoğlu, B Budakoğlu, İ Akmangit, N Zengin Supportive care in cancer 17, 399-403, 2009 | 36 | 2009 |
| Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey A Durnali, S Tokluoǧlu, N Özdemir, M Inanç, N Alkiş, N Zengin, Ö Sönmez, ... Asian Pacific Journal of Cancer Prevention 13 (5), 2012 | 33 | 2012 |
| The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma NY Özdemir, H Abalı, B Öksüzoğlu, B Budakoglu, D Uncu, T Güler, ... Medical Oncology 27, 680-684, 2010 | 31 | 2010 |
| Effect of port-care frequency on venous port catheter-related complications in cancer patients H Odabas, NY Ozdemir, I Ziraman, S Aksoy, H Abali, B Oksuzoglu, M Isik, ... International journal of clinical oncology 19, 761-766, 2014 | 29 | 2014 |
| Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients M Kos, C Hocazade, FT Kos, D Uncu, E Karakas, M Dogan, HG Uncu, ... Contemporary Oncology/Współczesna Onkologia 20 (2), 153-157, 2016 | 28 | 2016 |
| The relationship between platelet–lymphocyte ratio, neutrophil–lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus … M Dogan, T Eren, N Ozdemir, CL Cigirgan, N Zengin Saudi Journal of Gastroenterology 21 (5), 320-324, 2015 | 28 | 2015 |
| Current approaches for prophylactic cranial irradiation in extrapulmonary small cell carcinoma O Yazıcı, NY Ozdemir, MAN Sendur, S Aksoy, N Zengin Current medical research and opinion 30 (7), 1327-1336, 2014 | 27 | 2014 |
| Harmful consequences of COVID-19 fear in patients with cancer O Sutcuoglu, O Yazici, A Ozet, N Ozdemir BMJ supportive & palliative care 13 (e1), e102-e104, 2023 | 24 | 2023 |
| Small cell carcinoma of the urinary bladder: changing trends in the current literature GU Erdem, NY Özdemir, NS Demirci, S Şahin, Y Bozkaya, N Zengin Current Medical Research and Opinion 32 (6), 1013-1021, 2016 | 23 | 2016 |
| Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study N Ozdemir, H Abali, M Vural, S Yalcin, B Oksuzoglu, B Civelek, D Oguz, ... Cancer chemotherapy and pharmacology 74, 1139-1147, 2014 | 22 | 2014 |
| Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer FT Kos, D Uncu, N Özdemir, B Budakoglu, H Odabaş, H Abali, ... Chemotherapy 57 (3), 230-235, 2011 | 22 | 2011 |
| Evaluation of the effect of comorbidity on survival in pancreatic cancer by using'Charlson Comorbidity Index'and'Cumulative Illness Rating Scale'. FT Kos, O Yazici, B Civelek, M Seker, Z Arik, S Aksoy, D Uncu, N Ozdemir, ... Wiener klinische Wochenschrift 126, 2014 | 21 | 2014 |
| Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients D Uncu, S Aksoy, B Çetin, T Yetişyiğit, N Özdemir, V Berk, F Dane, A İnal, ... Oncology 84 (4), 240-245, 2013 | 21 | 2013 |
